ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
87.42
-2.58 (-2.87%)
At close: Aug 15, 2025, 3:59 PM
87.47
0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
ANI Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -8.41M | -19.24M | -16.72M | -5.29M | 27.02M | 35.55M | 18.78M | 13.38M | -5.16M | -26.33M | -47.9M | -67.79M | -63.64M | -62.82M | -42.6M | -22.1M | -17.22M | -15.45M |
Depreciation & Amortization | 84.52M | 75.94M | 67.73M | 60.33M | 59.78M | 59.78M | 59.79M | 60.17M | 60.31M | 59.8M | 59.65M | 57.77M | 53.76M | 50.91M | 47.25M | 44.47M | 44.48M | 44.35M |
Stock-Based Compensation | 33.02M | 31.28M | 29.34M | 27.9M | 25.86M | 23.25M | 20.65M | 18.77M | 17.19M | 15.7M | 14.6M | 13.83M | 12.77M | 11.86M | 10.49M | 9.91M | 9.49M | 12.38M |
Other Working Capital | 71.74M | 34.1M | 30.71M | 15.34M | 14.2M | 8.32M | 19.79M | 10.57M | -4.57M | 12.2M | 4.2M | -8.95M | -6.28M | -13.5M | -7.93M | 5.27M | 4.61M | -1.96M |
Other Non-Cash Items | 18.93M | 20.8M | 16.76M | 1.29M | -8.31M | -9.77M | 6.62M | 6.22M | 11.57M | 9.21M | 8.99M | 9.38M | 5.33M | 6.18M | 5.02M | 2.65M | 2.76M | 2.71M |
Deferred Income Tax | -30.04M | -28.4M | -21.91M | -12.73M | -10.4M | -9.41M | -11.74M | -5.02M | -4.01M | -7.02M | -15.25M | -21.72M | -21.46M | -23.94M | -16.75M | -12.84M | -5.78M | 5.76M |
Change in Working Capital | 41.11M | 369K | -11.19M | 21.4M | 18.63M | 16.41M | 24.86M | -23.7M | -38.63M | -42.2M | -51.3M | -30.45M | -34.78M | -18.48M | -84K | -12.29M | -20.14M | -15.53M |
Operating Cash Flow | 139.14M | 80.74M | 64.02M | 92.9M | 112.59M | 115.8M | 118.96M | 69.82M | 41.27M | 9.16M | -31.2M | -38.99M | -48.01M | -36.29M | 3.32M | 9.8M | 13.59M | 34.23M |
Capital Expenditures | -31.78M | -32.22M | -16.95M | -19.25M | -18.36M | -20.74M | -18.51M | -16.87M | -22.14M | -16.63M | -16.45M | -13.68M | -4.45M | -25.08M | -23.64M | -25.39M | -30.61M | -11.51M |
Cash Acquisitions | -414.79M | -414.79M | -401.28M | -393.08M | 13.51M | 13.51M | n/a | n/a | -33K | 684K | 684K | -83.81M | -83.78M | -84.49M | -84.49M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -18.42M | -18.42M | -1.04M | -959K | n/a | -4.33M | -4.33M | -4.33M | -4.3M | 775K | 550K | 3.2M | 3.16M | -18.61M | -18.42M | -21.08M | -25.11M | -6.22M |
Investing Cash Flow | -435.96M | -433.5M | -404.72M | -398.82M | -4.85M | -7.22M | -18.51M | -16.87M | -22.14M | -15.91M | -15.74M | -94.81M | -85.58M | -106.92M | -105.48M | -25.39M | -30.61M | -11.51M |
Debt Repayment | 342.66M | 343.94M | 345.22M | 346.5M | -3M | -3M | -3M | -3M | -3M | -3M | -3M | 80.81M | 78.73M | 76.65M | 75.02M | -10.41M | -9.96M | -17.01M |
Common Stock Repurchased | -11.55M | -12.3M | -10.96M | -10.87M | -10.86M | -10.1M | -4.99M | -4.88M | -4.44M | -4.39M | -1.96M | -1.84M | -1.68M | -1.66M | -890K | 634K | 707K | 140K |
Dividend Paid | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.63M | -1.41M | -1M | -595K | -190K | n/a | n/a | n/a |
Other Financial Acitivies | -46.8M | -46.8M | -59.25M | -78.27M | -20.44M | -23.24M | -13.17M | -1.87M | -1.39M | 1.61M | 1.46M | 97.27M | 96.66M | 120.66M | 120.65M | 24.24M | 24.36M | 337K |
Financial Cash Flow | 274.47M | 274.76M | 264.94M | 257.93M | -29.34M | 52.26M | 67.44M | 78.85M | 74.18M | -7.4M | -5.13M | 174.83M | 172.72M | 195.05M | 194.59M | 12.94M | 13.59M | -18.05M |
Net Cash Flow | -22.28M | -78.76M | -76.23M | -48.06M | 78.4M | 160.84M | 167.89M | 131.79M | 93.32M | -14.15M | -52.07M | 41.03M | 39.12M | 51.84M | 92.43M | -2.65M | -3.44M | 4.66M |
Free Cash Flow | 111.37M | 48.52M | 47.06M | 73.64M | 94.23M | 95.06M | 100.45M | 52.95M | 19.14M | -7.47M | -47.66M | -52.67M | -52.46M | -61.37M | -20.32M | -15.59M | -17.03M | 22.71M |